Marco Falcone, MD

Sapienza University of Rome, Italy

Disclosure(s): Gilead: Grant/Research Support; Infecto Pharm: Honoraria; Menarini: Honoraria; Pfizer: Honoraria; Shionogi: Honoraria; ViiV: Grant/Research Support

Poster(s):

• (P-1363) Optimizing Management of Infections Caused by Metallo‑β‑Lactamase (MBL)–Producing Enterobacterales: An International Modified Delphi Study
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET